Inizio is a global healthcare and life sciences partner that helps companies turn innovation into better outcomes for patients. Bringing together five specialized businesses, it connects strategic, analytical, scientific, and creative expertise to support products throughout clinical development and commercialization. Its services span discovery, development, pre-launch, launch, and post-launch, helping clients assess opportunities, advance assets, build evidence, engage decision-makers, and sustain impact.

Inizio Ignite provides strategy, transformation, research, data, and insights, including artificial intelligence solutions. Inizio Medical delivers medical affairs and scientific communications, while Inizio Evoke focuses on marketing and communications. Inizio Engage offers strategic commercial and creative engagement, and Inizio Biotech provides personalized solutions designed to maximize asset value. Across these businesses, Inizio supports commercialization strategy, product launches, congress experiences, omnichannel engagement, market access, pricing, patient services, and performance measurement. The company combines multidisciplinary expertise with data, technology, and AI to develop tailored support for healthcare and life sciences organizations. Its stated aim is to simplify complex challenges, unlock value, and help realize the potential of healthcare products.